{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:59:35Z","timestamp":1776916775869,"version":"3.51.2"},"reference-count":74,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/17\/45\/33071"],"award-info":[{"award-number":["PG\/17\/45\/33071"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The ongoing pandemic caused by the novel coronavirus has been the greatest global health crisis since the Spanish flu pandemic of 1918. Thus far, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in over 1 million deaths, and there is no cure or vaccine to date. The recently solved crystal structure of the SARS-CoV-2 main protease has been a major focus for drug-discovery efforts. Here, we present a fragment-guided approach using ZINCPharmer, where 17 active fragments known to bind to the catalytic centre of the SARS-CoV-2 main protease (SARS-CoV-2 Mpro) were used as pharmacophore queries to search the ZINC databases of natural compounds and natural derivatives. This search yielded 134 hits that were then subjected to multiple rounds of in silico analyses, including blind and focused docking against the 3D structure of the main protease. We scrutinised the poses, scores, and protein\u2013ligand interactions of 15 hits and selected 7. The scaffolds of the seven hits were structurally distinct from known inhibitor scaffolds, thus indicating scaffold novelty. Our work presents several novel scaffolds as potential candidates for experimental validation against SARS-CoV-2 Mpro.<\/jats:p>","DOI":"10.3390\/molecules25235501","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T09:06:28Z","timestamp":1606208788000},"page":"5501","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Novel Small-Molecule Scaffolds as Candidates against the SARS Coronavirus 2 Main Protease: A Fragment-Guided in Silico Approach"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0805-513X","authenticated-orcid":false,"given":"Teresa L.","family":"Augustin","sequence":"first","affiliation":[{"name":"Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxanna","family":"Hajbabaie","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew T.","family":"Harper","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3830-5160","authenticated-orcid":false,"given":"Taufiq","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020). The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol., 5, 536\u2013544.","DOI":"10.1038\/s41564-020-0695-z"},{"key":"ref_3","unstructured":"World Health Organization (2020, September 30). Coronavirus Disease (COVID-19) Pandemic. Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/s41591-020-0863-y","article-title":"If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future","volume":"26","author":"McKee","year":"2020","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1021\/acs.biochem.0c00160","article-title":"Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms","volume":"59","author":"Nutho","year":"2020","journal-title":"Biochemistry"},{"key":"ref_6","first-page":"516","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"137489","DOI":"10.1016\/j.cplett.2020.137489","article-title":"Identification of potential binders of the main protease 3CLpro of the COVID-19 via structure-based ligand design and molecular modeling","volume":"750","author":"Macchiagodena","year":"2020","journal-title":"Chem. Phys. Lett."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1073\/pnas.1835675100","article-title":"The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor","volume":"100","author":"Yang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science"},{"key":"ref_11","first-page":"1","article-title":"An Overview of the Crystallized Structures of the SARS-CoV-2","volume":"24","author":"Ionescu","year":"2020","journal-title":"Protein J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1021\/acs.jmedchem.5b01461","article-title":"An Overview of Severe Acute Respiratory Syndrome\u2013Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy","volume":"59","author":"Pillaiyar","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1128\/JVI.02612-07","article-title":"Without Its N-Finger, the Main Protease of Severe Acute Respiratory Syndrome Coronavirus Can Form a Novel Dimer through Its C-Terminal Domain","volume":"82","author":"Zhong","year":"2008","journal-title":"J. Virol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Reddy, V.P., Elkhateeb, E., Jo, H., Natalie, N., Lythgoe, E., Tang, W., Jamei, M., Sharma, S., and Hodjegan, A.R. (2020). Pharmacokinetics under the COVID-19 storm!. Drug Targets Potential Treat. J. Med. Chem.","DOI":"10.22541\/au.159335607.76402149"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm301580n","article-title":"Discovery, Synthesis, and Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease","volume":"56","author":"Jacobs","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants","volume":"10","author":"Alqahtani","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12900-015-0035-3","article-title":"Human coronavirus OC43 3CL protease and the potential of ML188 as a broad-spectrum lead compound: Homology modelling and molecular dynamic studies","volume":"15","author":"Berry","year":"2015","journal-title":"BMC Struct. Biol."},{"key":"ref_19","unstructured":"Mesecar, A.D. (2020). A taxonomically-driven approach to development of potent, broad-spectrum inhibitors of coronavirus main protease including SARS-CoV-2 (COVID-19). Unpublished work."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18709-w","article-title":"Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease","volume":"11","author":"Douangamath","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"W409","DOI":"10.1093\/nar\/gks378","article-title":"ZINCPharmer: Pharmacophore search of the ZINC database","volume":"40","author":"Koes","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jcc.20634","article-title":"A semiempirical free energy force field with charge-based desolvation","volume":"28","author":"Huey","year":"2007","journal-title":"J. Comput. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1002\/jcc.21797","article-title":"Fast docking using the CHARMM force field with EADock DSS","volume":"32","author":"Grosdidier","year":"2011","journal-title":"J. Comput. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","article-title":"Development and validation of a genetic algorithm for flexible docking 1 Edited by F. E. Cohen","volume":"267","author":"Jones","year":"1997","journal-title":"J. Mol. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.compbiolchem.2016.08.007","article-title":"Assessing the similarity of ligand binding conformations with the Contact Mode Score","volume":"64","author":"Ding","year":"2016","journal-title":"Comput. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Alexander, S.P., Ball, J.K., and Tsoleridis, T. (2020). Coronavirus (CoV) proteins (version 2020.5) in the IUPHAR\/BPS Guide to Pharmacology Database. IUPHAR\/BPS Guide Pharmacol. CITE, 2020.","DOI":"10.2218\/gtopdb\/F118\/2020.5"},{"key":"ref_29","unstructured":"(2020, September 13). PostEra COVID Moonshot. Available online: https:\/\/covid.postera.ai\/covid."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: Towards direct deposition of bioassay data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1016\/j.bmc.2010.09.035","article-title":"Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition","volume":"18","author":"Ryu","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1248\/cpb.40.127","article-title":"Simple Method of Calculating Octanol\/Water Partition Coefficient","volume":"40","author":"Moriguchi","year":"1992","journal-title":"Chem. Pharm. Bull."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/acschembio.7b00903","article-title":"Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017\u2014Utility and Limitations","volume":"13","author":"Baell","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A BOILED-Egg to Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/ci200387c","article-title":"Revisiting the General Solubility Equation: In Silico Prediction of Aqueous Solubility Incorporating the Effect of Topographical Polar Surface Area","volume":"52","author":"Ali","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/ci500467k","article-title":"iLOGP: A Simple, Robust, and Efficient Description of n-Octanol\/Water Partition Coefficient for Drug Design Using the GB\/SA Approach","volume":"54","author":"Daina","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41557-020-0496-2","article-title":"Crowdsourcing drug discovery for pandemics","volume":"12","author":"Chodera","year":"2020","journal-title":"Nat. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Li, Q., and Kang, C. (2020). Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease. Microorganisms, 8.","DOI":"10.3390\/microorganisms8081250"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Xu, C., Ke, Z., Liu, C., Wang, Z., Liu, D., Zhang, L., Wang, J., He, W., Xu, Z., and Li, Y. (2020). Systemic in Silico Screening in Drug Discovery for Coronavirus Disease (COVID-19) with an Online Interactive Web Server. J. Chem. Inf. Model., 28.","DOI":"10.26434\/chemrxiv.12058143"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/cb100105c","article-title":"Natural Products as Chemical Probes","volume":"5","author":"Carlson","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural Products as Sources of New Drugs over the Nearly Four Decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Rana, S., Sharma, S., and Ghosh, K. (2020). Virtual Screening of Naturally Occuring Antiviral Molecules for SARS-CoV-2 Mitigation Using Docking Tool on Multiple Molecular Targets. ChemRxiv, Available online: https:\/\/chemrxiv.org\/articles\/preprint\/Virtual_Screening_of_Naturally_Occurring_Antiviral_Molecules_for_SARS-CoV-2_Mitigation_Using_Docking_Tool_on_Multiple_Molecular_Targets\/12403940\/1.","DOI":"10.26434\/chemrxiv.12403940"},{"key":"ref_45","first-page":"113","article-title":"Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing","volume":"586","author":"Riva","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sharma, P., Vijayan, V., Pant, P., Sharma, M., Vikram, N., Kaur, P., Singh, T.P., and Sharma, S. (2020). Identification of potential drug candidates to combat COVID-19: A structural study using the main protease (mpro) of SARS-CoV-2. J. Biomol. Struct. Dyn., 1\u201311.","DOI":"10.1080\/07391102.2020.1798286"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"117627","DOI":"10.1016\/j.lfs.2020.117627","article-title":"Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease","volume":"251","author":"Kandeel","year":"2020","journal-title":"Life Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jiph.2020.06.016","article-title":"In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing","volume":"13","author":"Kumar","year":"2020","journal-title":"J. Infect. Public Health"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Lokhande, K.B., Doiphode, S., Vyas, R., and Swamy, K.V. (2020). Molecular docking and simulation studies on SARS-CoV-2 Mpro reveals Mitoxantrone, Leucovorin, Birinapant, and Dynasore as potent drugs against COVID-19. J. Biomol. Struct. Dyn., 1\u201312.","DOI":"10.1080\/07391102.2020.1805019"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Al-Khafaji, K., Al-Duhaidahawi, D.L., and Tok, T.T. (2020). Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2. J. Biomol. Struct. Dyn., 1\u20139.","DOI":"10.1080\/07391102.2020.1764392"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Mahanta, S., Chowdhury, P., Gogoi, N., Goswami, N., Borah, D., Kumar, R., Chetia, D., Borah, P., Buragohain, A.K., and Gogoi, B. (2020). Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: An in silico based approach. J. Biomol. Struct. Dyn., 1\u201310.","DOI":"10.1080\/07391102.2020.1768902"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1042\/BSR20201256","article-title":"Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible implication in COVID-19 therapy","volume":"40","author":"Shamsi","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1021\/acs.jmedchem.6b01437","article-title":"Recent Advances in Scaffold Hopping","volume":"60","author":"Hu","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"16469","DOI":"10.1038\/s41598-018-34677-0","article-title":"Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation","volume":"8","author":"Grisoni","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Gimeno, A., Mestres-Truyol, J., Ojeda-Montes, M.J., Macip, G., Saldivar-Espinoza, B., Cereto-Massagu\u00e9, A., Pujadas, G., and Garcia-Vallv\u00e9, S. (2020). Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21113793"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Koes, D.R., Pabon, N.A., Deng, X., Phillips, M.A., and Camacho, C.J. (2015). A Teach-Discover-Treat Application of ZincPharmer: An Online Interactive Pharmacophore Modeling and Virtual Screening Tool. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0134697"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00894-019-4032-5","article-title":"Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3\u03b2 inhibitors","volume":"25","author":"Osman","year":"2019","journal-title":"J. Mol. Model."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2174\/138620712803901090","article-title":"Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents","volume":"15","author":"Agrawal","year":"2012","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2014.12.051","article-title":"De novo design based pharmacophore query generation and virtual screening for the discovery of Hsp-47 inhibitors","volume":"456","author":"Katarkar","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: Fully automated protein\u2013ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1021\/ci200227u","article-title":"LigPlot+: Multiple Ligand\u2013Protein Interaction Diagrams for Drug Discovery","volume":"51","author":"Laskowski","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-69337-9","article-title":"Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates","volume":"10","author":"Yoshino","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13321-019-0373-4","article-title":"DLIGAND2: An improved knowledge-based energy function for protein\u2013ligand interactions using the distance-scaled, finite, ideal-gas reference state","volume":"11","author":"Chen","year":"2019","journal-title":"J. Cheminform."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"104697","DOI":"10.1016\/j.antiviral.2019.104697","article-title":"In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus","volume":"174","author":"Theerawatanasirikul","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Jeong, J., Kim, H., and Choi, J. (2019). In Silico Molecular Docking and In Vivo Validation with Caenorhabditis elegans to Discover Molecular Initiating Events in Adverse Outcome Pathway Framework: Case Study on Endocrine-Disrupting Chemicals with Estrogen and Androgen Receptors. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20051209"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"13150","DOI":"10.1038\/s41598-020-70042-w","article-title":"Structure\/activity virtual screening and in vitro testing of small molecule inhibitors of 8-hydroxy-5-deazaflavin:NADPH oxidoreductase from gut methanogenic bacteria","volume":"10","author":"Cuccioloni","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC-a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jcc.540150503","article-title":"ICM A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation","volume":"15","author":"Abagyan","year":"1994","journal-title":"J. Comput. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"113834","DOI":"10.1016\/j.bcp.2020.113834","article-title":"In silico screening of GMQ-like compounds reveals guanabenz and sephin1 as new allosteric modulators of acid-sensing ion channel 3","volume":"174","author":"Callejo","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"107662","DOI":"10.1016\/j.jmgm.2020.107662","article-title":"Proposed model of the Dictyostelium cAMP receptors bound to cAMP","volume":"100","author":"Greenhalgh","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13321-019-0362-7","article-title":"DockRMSD: An open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism","volume":"11","author":"Bell","year":"2019","journal-title":"J. Cheminform."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera-A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"ref_73","unstructured":"R Core Team (2016). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing."},{"key":"ref_74","unstructured":"ChemAxon (2020). Marvin, 20.16, ChemAxon Ltd."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/23\/5501\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:36:38Z","timestamp":1760178998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/23\/5501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":74,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["molecules25235501"],"URL":"https:\/\/doi.org\/10.3390\/molecules25235501","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]}}}